| 1. |
Bosch J, Pizcaeta P, Feu F,et al. Pathophysiology of portal hypertension. Gastroenterology Clinics of North America, 1992; 21(1)∶1.
|
| 2. |
三泽健之.肝硬变门脉压亢进症脾脏肿大诱导实验.日本消化病学会杂志，1994；88(16)∶2653.
|
| 3. |
Pique JM, Leung FV, Kitahora T, et al. Gastric mucosal blood flow and acid secretion in portal hypertension rats. Gastroenterology, 1988; 95(3)∶727.
|
| 4. |
Valla D, Gaudin C, Geoffroy P, et al. Reversal of adrenalineinduced increase in azygos blood flow in patients with cirrhosis receiving propranolol. J Hepatol, 1987; 4(1)∶86.
|
| 5. |
Lee H, Giroux L, Semret M, et al. Ritanserin decrease portal pressure in conscious and unrestrained cirrhotic rats. Gastroenterology, 1993; 5(3)∶1464.
|
| 6. |
Garia E, Nakata K. Localization of increased hepatic vascular resistance in liver cirrhosis. Hepatology, 1996; 11(8)∶230.
|
| 7. |
Benoit JN, Zimmerman B, Premen AJ, et al. Role of glucagon in splanchnic hyperemia of chronic portal hypertension. Am J Physiol, 1984; 247(9)∶E486.
|
| 8. |
Wu Y, Burn RC, Sitzmann JV. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension. Hepatology, 1993; 18(6);146.
|
| 9. |
Kravetz D, Arderiu MT, Bosch J, et al. Increased plasma volume in two models of portal hypertension in the rat∶cirrhosis of the liver and partial portal vein ligation. Am J Physiol, 1988; 254(3)∶G322.
|
| 10. |
Benoit JN, Barrowan JA, Harper SL,et al. Role of humoral factors in the intestinal hyperemia associated with chronic portal hypertension. Am J Physiol, 1986; 251(6)∶G674.
|
| 11. |
Pizcueta MP, Casamitjana R, Bosch J, et al. Decreased systemic vascular sensitivity to norepinephine in portal hypertensive rats:role of hyperglucogonism. Am J Physiol, 1990; 258(11)∶G191.
|
| 12. |
Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet, 1994; 43(1)∶776.
|
| 13. |
Pizcueta MP, Pique TM, Bosch J, et al. Effects of endogenous nitric oxide inhibition on the hemodynamic changes of portal hypertensive rats. Gastroenterology, 1994; 100(6)∶A785.
|
| 14. |
Korhuis RJ, Benoit JN, Kvietys PR, et al. Humoral factors may mediate increase rat hinoquanter blood flow in portal hypertension. Am J Physiol, 1985; 249(8)∶H827.
|
| 15. |
Bosch J. Splanchnic vasodilation and renal vasoconstriction;a key to the hepatorenal syndrome? Hepatology, 1990; 17(12)∶1445.
|
| 16. |
Albillos A, Colombatoto LA, Groszmann RI. Expansion of the sodium space in prehepatic portal hypertension∶further support for the peripheral vasodilation hypothesis of sodium retention. hepatology, 1990; 12(3)∶854.
|
| 17. |
Okimura H, Aramki T, Katsuta Y, et al. Reduction in hepatic venous pressure gradient as a consequence of volume contraction due to chronic administration of spinonolactone in patients with cirrhosis and no ascites. Am J Gastroenterol, 1994; 86(5)∶477.
|
1/5
WeChat